 |
|
Thrombolysis and StrokePast and Future
Michael A. Sloan, MD
Arch Neurol. 1987;44(7):748-768.
Abstract
• Investigators have tried to limit ischemic cerebral infarct size by pharmacologic and surgical means with mixed results. Thrombolytic (fibrinolytic) therapy has been used in the past with unfavorable outcome. With advances in clinical and radiologic assessment and new knowledge of the pathophysiology of brain ischemia, thrombolytic therapy has now become a feasible pharmacologic intervention in acute stroke. Central nervous system hemorrhage, the most dread complication of fibrinolytic therapy, is rare in patients with acute myocardial infarction favorably treated with these agents. Risk of hemorrhagic transformation of ischemic cerebral infarcts is related to size, location, and age of patient. Anticoagulation therapy may increase its size, but not its likelihood. The development of clot-specific agents, such as tissue-type plasminogen activator, and careful patient selection make fibrinolytic therapy safe and potentially effective in acute stroke.
Author Affiliations
From the Department of Neurology, Tufts New England Medical Center, Boston. Dr Sloan is now with the Department of Neurology, University of Virginia Medical Center, Charlottesville.
Footnotes
Accepted for publication March 5, 1987.
Reprint requests to Department of Neurology, University of Virginia Medical Center, Box 394, Charlottesville, VA 22908 (Dr Sloan).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
The Future of Acute Stroke Treatment: Lessons We Have Learned From Laboratory and Clinical Research
Frey
Arch Intern Med 1995;155:1005-1006.
ABSTRACT
Streptokinase in the Treatment of an Acute Cerebral Embolus A Case Report
Frink and Ostrach
ANGIOLOGY 1990;41:66-69.
ABSTRACT
Ruptured Arteriovenous Malformation Complicating Thrombolytic Therapy With Tissue Plasminogen Activator
Proner et al.
Arch Neurol 1990;47:105-106.
ABSTRACT
Treatment for Stroke
Gilson
ANN INTERN MED 1989;111:1048-1049.
ABSTRACT
Acute Cerebral Ischemia in a Critical Care Unit: A Review of Diagnosis and Management
Levine
Arch Intern Med 1989;149:90-98.
ABSTRACT
Intracerebral Hemorrhage Complicating Intravenous Tissue Plasminogen Activator Treatment
Carlson et al.
Arch Neurol 1988;45:1070-1073.
ABSTRACT
Tissue Plasminogen Activator: Reduction of Neurologic Damage After Experimental Embolic Stroke
Zivin et al.
Arch Neurol 1988;45:387-391.
ABSTRACT
|
